12. Zhang LX, Li CX, Kakar MU, Khan MS, Wu PF, Amir RM, Dai DF, Naveed M, Li QY, Saeed M, Shen JQ.
Resveratrol (RV): A pharmacological review and call for further research. Biomed Pharmacother 2021; 143: 112164.
17. Fuggetta MP, Bordignon V, Cottarelli A, Macchi B, Frezza C, Cordiali-Fei P, Ensoli F, Ciafrè S, Marino-Merlo F, Mastino A, Ravagnan G.
Downregulation of proinflammatory cytokines in HTLV-1-infected T cells by Resveratrol. J Exp Clin Cancer Res 2016; 35(1): 1-9.
22. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC.
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997; 275(5297): 218-220.
23. Hou Y, Zhang Y, Mi Y, Wang J, Zhang H, Xu J, Yang Y, Liu J, Ding L, Yang J, Chen G.
A Novel Quinolyl‐Substituted Analogue of Resveratrol Inhibits LPS‐Induced Inflammatory Responses in Microglial Cells by Blocking the NF‐κB/MAPK Signaling Pathways. Mole Nutr Food Res 2019; 63(20): 1801380.
27. Pinheiro DM, de Oliveira AH, Coutinho LG, Fontes FL, de Medeiros Oliveira RK, Oliveira TT, Faustino AL, da Silva VL, de Melo Campos JT, Lajus TB, de Souza SJ.
Resveratrol decreases the expression of genes involved in inflammation through transcriptional regulation. Free Rad Biol Med 2019; 130: 8-22.
35. Shah S, Ahmed MM, Mahmood-ur-Rahman, Chaudhry Z, Aslam A, Nisar N, Abbas G, Khurram H, Mukhtar A, Noureen S, Zulfiqar N.
Utilization of Self-Medication, Prescription Medication and Herbal Remedies During Pregnancy in Punjab, Pakistan. Lat Am J Pharm 2021; 40(2): 339-346.
55. Cui X, Jin Y, Hofseth AB, Pena E, Habiger J, Chumanevich A, Poudyal D, Nagarkatti M, Nagarkatti PS, Singh UP, Hofseth LJ.
Resveratrol suppresses colitis and colon cancer associated with colitis. Cancer Preven Res 2010; 3: 549-559.
62. Wang TT, Hudson TS, Wang TC, Remsberg CM, Davies NM, Takahashi Y, Kim YS, Seifried H, Vinyard BT, Perkins SN, Hursting SD.
Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo. Carcinogenesis 2008; 29: 2001-2010.
67. Yu YH, Chen HA, Chen PS, Cheng YJ, Hsu WH, Chang YW, Chen YH, Jan Y, Hsiao M, Chang TY, Liu YH.
MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol. Oncogene 2013; 32: 431-443.
70. Hecht SS, Kenney PM, Wang M, Trushin N, Agarwal S, Rao AV, Upadhyaya P.
Evaluation of butylated hydroxyanisole, myo-inositol, curcumin, esculetin, resveratrol and lycopene as inhibitors of benzo[a]pyrene plus 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice. Cancer Lett 1999; 137: 123-130.
)
)